A U.S. pharmaceutical developer focused on branded prescription medicines, particularly in central nervous system disorders, cardiovascular disease, and gastrointestinal treatments. The company built its portfolio through drug licensing and commercialization partnerships, with products such as Lexap...
1 member of Congress has disclosed 1 trade in Forest Laboratories (merged with Actavis) (FRX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 0 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2014-07-01 | HOWARD COBLE | exchange | $1K – $15K |